Hunan Jiudian Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Hunan Jiudian Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hunan Jiudian Pharmaceutical Co Ltd (300705) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥180.33 Million ≈ $26.39 Million USD) by net assets (CN¥2.66 Billion ≈ $388.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hunan Jiudian Pharmaceutical Co Ltd (2013–2025)
Cash flow conversion efficiency of Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2025. This chart illustrates how Hunan Jiudian Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300705 live share price for real-time trading data and today's change.
Hunan Jiudian Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Hunan Jiudian Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hunan Jiudian Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Jiudian Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 300705 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SGSG Science&technology Co Ltd Zhuhai
SHE:300561
|
0.008x |
|
Hangzhou Greenda Electronic Materials Co Ltd
SHG:603931
|
0.028x |
|
Aktis Oncology, Inc. Common stock
NASDAQ:AKTS
|
0.097x |
|
Hainan Shennong Technology Co Ltd
SHE:300189
|
0.008x |
|
Latham Group Inc
NASDAQ:SWIM
|
0.130x |
|
PLAYTIKA HOLDING DL-01
F:8II
|
-0.695x |
|
Shanghai Baosteel Packaging
SHG:601968
|
0.070x |
|
Collins Foods Ltd
AU:CKF
|
0.166x |
Annual Cash Flow Conversion Efficiency for Hunan Jiudian Pharmaceutical Co Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2025. Review Hunan Jiudian Pharmaceutical Co Ltd (300705) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.79 Billion ≈ $407.71 Million |
CN¥647.06 Million ≈ $94.68 Million |
0.232x | -21.38% |
| 2024-12-31 | CN¥2.53 Billion ≈ $369.74 Million |
CN¥746.36 Million ≈ $109.22 Million |
0.295x | +35.18% |
| 2023-12-31 | CN¥1.97 Billion ≈ $288.75 Million |
CN¥431.19 Million ≈ $63.10 Million |
0.219x | +26.13% |
| 2022-12-31 | CN¥1.55 Billion ≈ $227.20 Million |
CN¥268.99 Million ≈ $39.36 Million |
0.173x | -0.22% |
| 2021-12-31 | CN¥1.10 Billion ≈ $160.87 Million |
CN¥190.87 Million ≈ $27.93 Million |
0.174x | -3.27% |
| 2020-12-31 | CN¥835.68 Million ≈ $122.29 Million |
CN¥149.99 Million ≈ $21.95 Million |
0.179x | +50.70% |
| 2019-12-31 | CN¥761.87 Million ≈ $111.49 Million |
CN¥90.74 Million ≈ $13.28 Million |
0.119x | +25.36% |
| 2018-12-31 | CN¥718.16 Million ≈ $105.09 Million |
CN¥68.23 Million ≈ $9.98 Million |
0.095x | -21.99% |
| 2017-12-31 | CN¥660.26 Million ≈ $96.62 Million |
CN¥80.42 Million ≈ $11.77 Million |
0.122x | -28.61% |
| 2016-12-31 | CN¥323.43 Million ≈ $47.33 Million |
CN¥55.18 Million ≈ $8.07 Million |
0.171x | +34.88% |
| 2015-12-31 | CN¥254.51 Million ≈ $37.24 Million |
CN¥32.20 Million ≈ $4.71 Million |
0.126x | -11.82% |
| 2014-12-31 | CN¥209.87 Million ≈ $30.71 Million |
CN¥30.11 Million ≈ $4.41 Million |
0.143x | -17.81% |
| 2013-12-31 | CN¥175.85 Million ≈ $25.73 Million |
CN¥30.69 Million ≈ $4.49 Million |
0.175x | -- |
About Hunan Jiudian Pharmaceutical Co Ltd
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches,… Read more